Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-22-011211
Filing Date
2022-07-28
Accepted
2022-07-28 08:29:26
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K argx-20220630x6k.htm 6-K 35195
2 EX-99.1 argx-20220630xex99d1.htm EX-99.1 174224
3 EX-99.2 argx-20220630xex99d2.htm   iXBRL EX-99.2 1091631
4 GRAPHIC argx-20220630xex99d1001.jpg GRAPHIC 3320
  Complete submission text file 0001558370-22-011211.txt   4585141

Data Files

Seq Description Document Type Size
5 EX-101.SCH argx-20220630.xsd EX-101.SCH 52581
6 EX-101.CAL argx-20220630_cal.xml EX-101.CAL 63348
7 EX-101.DEF argx-20220630_def.xml EX-101.DEF 101791
8 EX-101.LAB argx-20220630_lab.xml EX-101.LAB 317811
9 EX-101.PRE argx-20220630_pre.xml EX-101.PRE 221165
65 EXTRACTED XBRL INSTANCE DOCUMENT argx-20220630xex99d2_htm.xml XML 713969
Mailing Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 221112930
SIC: 2836 Biological Products, (No Diagnostic Substances)